Skip to content

Public FDA record

Z-0429-2021: XTANT Medical, ## mm x ## mm x # mm x # ,Lordotic/Packaged InTice - C, Sterile R, Single Use Only, for t

Recall record Z-0429-2021 for XTANT Medical. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0429-2021
Company in FDA record
XTANT Medical
FDA record creation date
Nov 6, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class III

Reason stated in the source

Cervical Implants contain a label that incorrectly identifies the grade of titanium used.

Source facts

Action
On 9/30/2020 and 10/29/2020, a "Urgent: Medical Device Recall" notification was sent to consignees via FedEx Priority Overnight. In addition to notifying the consignee about the labeling issue, the recall notification as consignees to take the following actions: 1. Immediately examine your inventory and quarantine any affected products subject to this recall. See enclosed illustration for ease in identifying affected products (see Attachment 2). 2. Please complete the enclosed Acknowledgement Form (Attachment 1), even if you have no remaining devices in your inventory, and return the completed Acknowledgment Form to the Attention of Michele Dolan via: Mail: Xtant Medical InTice-C Porous Ti Cervical Interbody System Recall 664 Cruiser Lane Belgrade, MT 59714 Email: mdolan@xtantmedical.com Fax:1-406-388-3380 3. Return Affected Product Contact Michele Dolan at mdolan@xtantmedical.com, or 1-406-388-0480 ext. 1127, between 8 a.m. and 5 p.m. (Mountain Time) to obtain instructions for returning affected product, and to obtain replacement devices which will be provided at no cost to you. 4. Package the affected products to be returned. Xtant will provide a shipping container (if needed) with a return shipping label. Securely package the affected product(s). Send the container at your earliest opportunity to: ATTN: InTice-C Porous Ti Cervical Interbody System Recall RA# 20-xxxx Xtant Medical 732 Cruiser Lane Belgrade, MT 59714 If you have any questions, please contact Rebecca Lennemann, Director of RAQA, 1-406-388-0480 ext. 1125, from 8 a.m. to 5 p.m. (Mountain Time). For consignees that have already implanted the device: 1. The product does not pose any health risk. The product is correctly manufactured with commercially pure Titanium (CP-Ti), Grade 2, and as such, there is no need for surgical intervention. 2. This notice is being provided only as a notification of the recall and requires completion of the Customer Acknowl
Initiated
2020-09-30
Root cause
Labeling mix-ups
Terminated
2021-05-21
Distribution
US: FL, TX, CA, OH, AZ, OH OUS: None
Recall number
Z-0429-2021
Recall status
Terminated
CDRH record ID
184167
FDA record created
2020-11-06
Recall event number
86602

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗